The authors wish to correct a typographical error in the
manuscript. In both the abstract and Section 3.4 of the original manuscript, a
1-point increase in the Dublin-Boston score was described as being associated
with a 5.6 times increased odds (OR 5.62, 95% CI = 3.229.81, P = 1.2 £ 109 )
for a more severe outcome. While the OR and P-value stated are correct, the CI
should instead have read “3.229.81”. The CI listed in Table 3 of the original
manuscript, which accompanied Section 3.4, is correct. The authors regret any
confusion caused, and appreciate the opportunity to correct this mistake.
History
Comments
The original article is available at https://www.thelancet.com/ Corrigendum for EBioMedicine. 2020;61:103026. https://doi.org/10.1016/j.ebiom.2020.103026
Published Citation
McElvaney OJ. et al. Corrigendum to 'A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19'. EBioMedicine. 2020;62:103116